门诊医疗中的药物不良事件:一项横断面研究
该横断面研究利用某学术医疗中心2018年10月至2019年12月的门诊电子健康记录,基于994个ADE相关ICD-10编码分层抽样并人工标注临床笔记,估算门诊ADE的患病率与特征。共纳入3126份笔记(2882例患者),44.2%的就诊记录了现患或可能的ADE,现患ADE的总体患病率估计为每100次就诊1.97次(含可能ADE为2.52次)。
要点
- 门诊就诊中现患ADE的总体患病率估计为每100次就诊1.97次。
- 44.2%的被抽样就诊记录了现患或可能的ADE。
- 主要致病药物类别为抗感染药、中枢神经系统药和心血管药。
核心结论
- 利用ICD-10编码结合临床笔记标注可估算门诊ADE的总体患病率,增进药物警戒知识。
研究设计与样本
- 横断面研究,纳入某学术医疗中心2018年10月1日至2019年12月31日有门诊就诊的患者电子健康记录。
- 基于994个ADE相关ICD-10编码制定分层抽样策略,随机抽取临床笔记并标注ADE-药物关系及严重程度。
- 共纳入3126份笔记(对应2882例独特患者),并与大型商业数据库比较ICD-10编码频率以评估泛化性。
主要发现
- 1383次就诊(44.2%)记录了现患或可能的ADE,共6308次提及。
- 在6038次ADE提及中,14.1%为过敏反应,1.1%为危及生命,22.4%为严重,60.4%为显著。
- 主要致病药物包括抗感染药(19.3%)、中枢神经系统药(12.8%)和心血管药(11.5%)。
- 临床笔记中现患ADE的总体患病率估计为每100次就诊1.97次,含可能ADE时为每100次就诊2.52次。
临床怎么用
- 门诊应关注抗感染药、中枢神经系统药和心血管药相关ADE的识别与监测。
- 利用ICD-10编码结合临床笔记文本可辅助药物警戒检测和ADE预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adverse drug events (ADEs) are understudied in the ambulatory care setting. We aim to estimate the prevalence and characteristics of ADEs in outpatient care using electronic health records (EHRs). METHODS: This cross-sectional study included EHR data for patients who had an outpatient encounter at an academic medical center from 1 October 2018 through 31 December 2019. We developed a stratified sampling strategy based on a comprehensive set of 994 ADE-related International Classification of Disease (ICD-10) codes to identify clinical encounters and notes likely to contain ADEs. Within each ICD-10 likelihood group, clinical notes were randomly sampled and annotated for present or possible ADE-drug relationships and severity. The overall estimated population prevalence of ADEs presenting in the outpatient setting was calculated. The generalizability of the findings was assessed by comparing ICD-10 code frequencies against a large commercial database. RESULTS: The study included 3126 notes (unique patient encounters) from 2882 unique patients. Of these, 1383 patient encounters (44.2%) had a present or possible ADE documented (6308 mentions). Of the 6038 ADEs mentioned, 14.1% were hypersensitivity reactions, 1.1% were life-threatening, 22.4% were serious, and 60.4% were significant. Main causal agents included anti-infectives (19.3%), central nervous system agents (12.8%), and cardiovascular agents (11.5%). The overall prevalence of present ADEs mentioned in the clinical notes was estimated to be 1.97 per 100 patient encounters (or 2.52 per 100 patient encounters when possible ADEs are included). CONCLUSIONS: This study identified the overall population prevalence per encounter of ADEs in the outpatient population by leveraging ICD-10 codes and investigating ADEs documented in clinical notes. Understanding the ADE characteristics in a large corpus of outpatient documentation advances pharmacovigilance knowledge, enhancing the detection, monitoring, and prevention of ADEs in ambulatory care. Patients who take medications at home may experience uncomfortable or harmful effects as a reaction to that medication. This harm experienced by a patient is known as an adverse drug event. The patient may seek care at their doctor or urgent care facility to help treat unexpected reactions. Patients visit their doctor for various reasons, but this study found that 1.97 out of every 100 patient visits are to address an adverse drug event.
引用
- Plasek JM, Amato MG, Salem A, et al. Adverse Drug Events in Ambulatory Care: A Cross-Sectional Study. Drug Saf. 2024. PMID: 39621298. doi:10.1007/s40264-024-01501-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。